{"id":5601,"date":"2020-03-18T11:07:13","date_gmt":"2020-03-18T03:07:13","guid":{"rendered":"http:\/\/web.csh.org.tw\/web\/doctor\/?page_id=5601"},"modified":"2024-04-23T13:50:38","modified_gmt":"2024-04-23T05:50:38","slug":"%e5%b7%ab%e5%ba%b7%e7%86%99%e6%95%99%e6%8e%88","status":"publish","type":"page","link":"https:\/\/web.csh.org.tw\/web\/doctor\/?page_id=5601","title":{"rendered":"\u5deb\u5eb7\u7199\u91ab\u5e2b"},"content":{"rendered":"\n
\u91ab\u5e2b\u59d3\u540d\uff1a\u5deb\u5eb7\u7199<\/strong>\u3000(Wu, Kang-Hsi)\u3000
<\/td><\/tr>
\u73fe\u8077\/\u6559\u8077
\u2022\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u79d1 \u4e3b\u4efb
\u2022\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78 \u91ab\u5b78\u7cfb \u6559\u6388
\u2022\u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u53ca\u9aa8\u9ad3\u79fb\u690d\u5b78\u6703 \u7406\u4e8b             
\u2022\u81fa\u7063\u4e2d\u897f\u6574\u5408\u91ab\u5b78\u6703 \u5e38\u52d9\u7406\u4e8b
\u2022\u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u75c5\u5b78\u6703 \u6307\u5c0e\u91ab\u5e2b
\u2022\u4e2d\u83ef\u6c11\u570b\u5152\u7ae5\u764c\u75c7\u57fa\u91d1\u6703 \u5de5\u4f5c\u5c0f\u7d44\u59d4\u54e1\u6703 \u59d4\u54e1
\u2022\u4e2d\u83ef\u6c11\u570b\u5152\u7ae5\u764c\u75c7\u57fa\u91d1\u6703 \u53f0\u7063\u5152\u7ae5\u764c\u75c7\u7814\u7a76\u7fa4 \u9867\u554f\u91ab\u5e2b
\u2022\u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u4e00\u822c\u59d4\u54e1\u6703\/\u6b21\u5c08\u79d1\u59d4\u54e1\u6703 \u59d4\u54e1
\u2022\u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u53ca\u9aa8\u9ad3\u79fb\u690d\u5b78\u6703 \u7bc0\u76ee\u59d4\u54e1\u6703\/\u79fb\u690d\u767b\u9304\u8a08\u756b\u59d4\u54e1\u6703\/\u5b78\u8853\u7814\u7a76\u59d4\u54e1\u6703 \u59d4\u54e1
\u2022\u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u5152\u79d1\u6700\u524d\u7dda \u526f\u7e3d\u7de8\u8f2f
\u2022\u570b\u79d1\u6703 \u8907\u5be9\u59d4\u54e1
\u2022\u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u6559\u6388 (\u6559\u5b57\u7b2c141601\u865f\uff1b2014\u5e748\u6708\u8fc4\u4eca)
\u2022\u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u526f\u6559\u6388 (\u526f\u5b57\u7b2c040201\u865f\uff1b2010\u5e748\u6708-2014\u5e747\u6708)
\u2022\u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u52a9\u7406\u6559\u6388 (\u52a9\u7406\u5b57\u7b2c020163\u865f\uff1b2007\u5e741\u6708-2010\u5e747\u6708)
\u2022\u6559\u80b2\u90e8\u5be9\u5b9a\u5408\u683c\u8b1b\u5e2b (\u8b1b\u5b57\u7b2c077537\u865f\uff1b2004\u5e741\u6708-2006\u5e7412\u6708)
<\/td><\/tr>
\u5c08\u9577
\u2022\u5152\u7ae5\u60e1\u6027\u53ca\u826f\u6027\u816b\u7624 (\u5305\u62ec\u4e0d\u660e\u816b\u584a\/\u816b\u7624\u3001\u8840\u7ba1\u7624)
\u2022\u8840\u6db2\u75be\u75c5 (\u5305\u62ec\u8ca7\u8840\u3001\u7d2b\u6591\u75c7\u3001\u767d\u8840\u7403\u904e\u9ad8\/\u904e\u4f4e)
\u2022\u5c0f\u5152\u75be\u75c5 (\u5305\u62ec\u4e0d\u660e\u539f\u56e0\u767c\u71d2)
\u2022\u9aa8\u9ad3\u79fb\u690d (\u5305\u62ec\u81cd\u5e36\u8840\u79fb\u690d\u3001\u5468\u908a\u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d\u9aa8\u9ad3\u79fb\u690d)
\u2022\u5e79\u7d30\u80de\u8f49\u8b6f\u91ab\u5b78<\/td><\/tr>
\u5b78\u7d93\u6b77
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78 \u91ab\u5b78\u58eb
\u2022\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u79d1\u4e3b\u4efb
\u2022\u53f0\u5927\u91ab\u9662\u5152\u79d1\u90e8 \u5c0f\u5152\u8840\u6db2\u816b\u7624\u79d1\u7814\u7a76\u91ab\u5e2b
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u5152\u7ae5\u91ab\u9662 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u79d1\u4e3b\u4efb
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u5152\u7ae5\u91ab\u9662 \u5152\u7ae5\u816b\u7624\u59d4\u54e1\u6703 \u4e3b\u4efb\u59d4\u54e1
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u6aa2\u9a57\u91ab\u5b78\u90e8\u8840\u5eab\u4e3b\u4efb
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u5152\u7ae5\u91ab\u9662 \u8840\u6db2\u816b\u7624\u75c5\u623f \u75c5\u623f\u4e3b\u4efb
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u7d44\u7e54\u5eab\u66a8\u8840\u6db2\u5e79\u7d30\u80de\u7814\u7a76\u5ba4\u9867\u554f\u91ab\u5e2b
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u79fb\u690d\u59d4\u54e1\u6703\/\u8f38\u8840\u59d4\u54e1\u6703\/\u7d44\u7e54\u5eab\u59d4\u54e1\u6703\/\u75c5\u623f\u7ba1\u7406\u59d4\u54e1\u6703\/\u5b89\u5be7\u7642\u8b77\u59d4\u54e1\u6703 \u59d4\u54e1
\u2022\u4e2d\u570b\u91ab\u85e5\u5927\u5b78 \u5b78\u58eb\u5f8c\u4e2d\u91ab\u5b78\u7cfb \u7cfb\u4e3b\u4efb
\u2022\u4e2d\u83ef\u6c11\u570b\u95dc\u61f7\u8166\u7624\u5152\u7ae5\u5354\u6703 \u9867\u554f\u91ab\u5e2b
\u2022\u4e2d\u83ef\u6c11\u570b\u559c\u9858\u5354\u6703 \u9867\u554f\u91ab\u5e2b
\u2022\u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703 \u5c08\u79d1\u91ab\u5e2b\u7504\u9078\u59d4\u54e1\u6703 \u59d4\u54e1
\u2022\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662\u526f\u9662\u9577 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/td><\/tr>
\u5c08\u79d1\u91ab\u5e2b
\u2022\u53f0\u7063\u5152\u79d1\u91ab\u5b78\u6703\u5152\u79d1\u5c08\u79d1\u91ab\u5e2b
\u2022\u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u53ca\u9aa8\u9ad3\u79fb\u690d\u5c08\u79d1\u91ab\u5e2b
\u2022\u4e2d\u83ef\u6c11\u570b\u8840\u6db2\u75c5\u5c08\u79d1\u91ab\u5e2b<\/td><\/tr>
\u5152\u7ae5\u8840\u6db2\u816b\u7624\u75be\u75c5\u76f8\u95dcYouTube<\/strong>
\u2022\u5152\u7ae5\u764c\u75c7\u4ecb\u7d39\u9996\u90e8\u66f2<\/a>
\u2022\u5152\u7ae5\u8ca7\u8840\u548c\u8840\u5c0f\u677f\u4f4e\u4e0b\u4ecb\u7d39<\/a>
\u2022\u5152\u7ae5\u8840\u7ba1\u7624\u548c\u9aa8\u9ad3\u79fb\u690d\u4ecb\u7d39<\/a>
\u2022\u3010\u5168\u6c11\u5065\u5eb7\u4fdd\u5065378\u3011WXTV\u552f\u5fc3\u96fb\u8996\u53f0<\/a>
\u2022\u3010\u5168\u6c11\u5065\u5eb7\u4fdd\u5065379\u3011WXTV\u552f\u5fc3\u96fb\u8996\u53f0<\/a>
\u2022\u3010\u5168\u6c11\u5065\u5eb7\u4fdd\u5065380\u3011WXTV\u552f\u5fc3\u96fb\u8996\u53f0<\/a>
<\/td><\/tr>
\u5a92\u9ad4\u5831\u5c0e<\/strong>
\u2022\u7236\u5b50\u540c\u5fc3\u540c\u201d\u9ad3\u201d\u5e0c\u6230\u52dd\u5152\u7ae5\u9ad8\u60e1\u6027\u816b\u7624<\/a> (2020)
\u2022\u4e2d\u5c71\u9644\u91ab\u6210\u7acb\u8840\u6db2\u75c5\u4e2d\u5fc3<\/strong> \u60a3\u8005\u4ee5\u6b4c\u8072\u548c\u5409\u4ed6\u6f14\u594f\u795d\u8cc0<\/a> (2020)
\u2022\u5152\u7ae5\u5b89\u5be7<\/strong>\uff01\u54c8\u97d3\u5c11\u5973\u5370\u624b\u6a21\u7559\u7236\u6bcd\u542b\u7b11\u96e2\u4e16<\/a> (2020)
\u2022\u5370\u50ad\u5e7c\u5973\u7f79\u8840\u764c<\/strong>\u53f0\u7063\u8001\u95c6\u9019\u9ebc\u505a\u6696\u54ed\u773e\u4eba<\/a> (2020)
\u2022\u6d77\u6d0b\u6027\u8ca7\u8840<\/strong>\u9577\u671f\u8f38\u8840\u9435\u8cea\u6613\u904e\u91cf\u7d2f\u7a4d <\/a>
\u91ab\u5b78\u7a81\u7834\u514d\u4fb5\u5165\u5075\u6e2c\u5fc3\u81df\u3001\u809d\u81df\u9435\u8cea\u6c88\u7a4d\u91cf<\/a> (2020)
\u2022\u5e6b\u4e94\u6708\u5927\u5b30\u5152\u6d17\u6fa1\u6478\u5230\u816b\u584a \u7adf\u662f\u809d\u6bcd\u7d30\u80de\u764c<\/strong><\/a> (2016)
\u2022\u570b\u4e09\u5973\u6230\u52dd\u60e1\u6027\u6dcb\u5df4\u764c<\/strong> \u69ae\u7372\u7e3d\u7d71\u6559\u80b2\u734e<\/a> (2016)
\u2022\u6297\u8840\u764c<\/strong>\u5c0f\u9b25\u58eb\u8b8a\u767d\u8863\u5929\u4f7f \u5979\u7acb\u5fd7\u5b88\u8b77\u764c\u7ae5<\/a> (2015)
\u2022\u300c\u5149\u982d\u752d\u5439\u9aee\u300d\u7ae5\u6a02\u89c0\u6297\u764c<\/a> (2014)
\u2022\u8ce3\u9905\u7f55\u898b\u8840\u6db2\u75c5\u7ae5<\/strong>\u51fa\u9662 \u597d\u60f3\u4e0a\u5b78<\/a> (2014)
\u2022\u6350\u5e79\u7d30\u80de\u6551\u4eba\u3000\u65b0\u6350\u9ad3\u6280\u8853\u7121\u5f8c\u907a\u75c7<\/a> (2013)
\u2022\u5168\u7403\u9996\u4f8b \u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de<\/strong>-\u6551\u8840\u6db2\u75c5\u60a3 \u79fb\u690d7\u5929\u5c31\u80fd\u9020\u8840<\/a> (2011)
\u2022921\u707d\u6c11\u6551\u8840\u764c<\/strong>\u5973 \u96e3\u625b\u91ab\u8cbb<\/a> (2010)
\u2022\u8a72\u70ba\u5bf6\u5bf6\u5b58\u81cd\u5e36\u8840<\/strong>\u55ce\uff1f<\/a> (2008)
\u2022\u4f86\u53f0\u63db\u9aa8\u9ad3<\/strong> \u8607\u4e39\u7537\u7ae5\u958b\u5fc3\u8fd4\u5bb6<\/a> (2008)
\u2022\u6148\u6bcd\u6350\u96a8<\/strong>\u6551\u91cd\u75c5\u611b\u5973 \u914d\u5c0d\u50c56\u6210\u543b\u5408 \u570b\u5167\u9996\u4f8b\u6210\u529f<\/a> (2005)
\u2022\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de<\/a><\/strong>\u4eba\u9ad4\u8a66\u9a57\u6210\u529f<\/a>
\u2022\u3010\u5168\u570b\u9996\u4f8b\u3011\u7f79\u60e1\u6027\u795e\u7d93\u6bcd\u7d30\u80de\u764c \u9760\u81cd\u5e36\u8840\u81ea\u6551<\/a>
\u2022\u9996\u4f8b \u81ea\u5b58\u81cd\u5e36\u8840 \u7fa9\u6350\u6551\u547d<\/a> (2007)
\u2022\u6297\u764c\u5c11\u5973 \u75c5\u53f2\u7de8\u6210\u821e<\/a> (2007)
\u2022\u6bcd\u5403\u6ce1\u9eb5\u7701\u9322\u7c4c<\/a>\u8840\u764c<\/a><\/strong>\u5152\u91ab\u8cbb<\/a> (2007)<\/td><\/tr>
\u76f8\u95dc\u9023\u7d50
\u2022 \u8840\u6db2\u548c\u816b\u7624\u75c5\u7ae5\u7684\u91ab\u5b78\u4e2d\u5fc3<\/a>
\u2022 \u5e79\u7d30\u80de\u7c21\u4ecb \u5f9e\u9020\u8840\u5e79\u7d30\u80de\u5230\u9593\u8cea\u5e79\u7d30\u80de<\/a><\/td><\/tr><\/tbody><\/table>\n\n\n\n
\"\"






































































<\/figcaption><\/figure>\n\n\n\n

\u69ae\u8b7d(Honor)<\/strong>
\u20222008\u5e74\u5546\u696d\u5468\u520a\u767e\u5927\u826f\u91ab\u63a8\u85a6\u597d\u91ab\u5e2b
\u20222012 & 2018\u5e74\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662\u5091\u51fa\u91ab\u5e2b
\u20222003 & 2004\u5e74\u4e2d\u570b\u91ab\u85e5\u5927\u5b78\u9644\u8a2d\u91ab\u9662\u512a\u826f\u91ab\u5e2b
\u2022\u97d3\u570b\u3001\u8d8a\u5357\u3001\u4e9e\u7f8e\u5c3c\u4e9e\u7b49\u591a\u570b\u91ab\u5e2b\u4f86\u53f0\u5411\u5deb\u91ab\u5e2b\u5b78\u7fd2
\u20222008~2012\u5e74\u570b\u969b\u6703\u8b70
  Pan Pacific Symposium on Stem Cells and Cancer Research
  \u7d44\u7e54\u59d4\u54e1\u6703\u59d4\u54e1
\u2022\u591a\u6b21\u570b\u969b\u5927\u6703\u61c9\u9080\u6f14\u8b1b\u53ca\u4e3b\u6301\u4eba
\u2022\u70ba\u570b\u969b\u77e5\u540dSCI\u91ab\u5b78\u671f\u520a\u8ad6\u6587\u5be9\u7a3f\u5b78\u8005(reviewer)
\u2022\u767c\u8868\u4e0a\u767e\u7bc7\u8ad6\u6587\u65bc\u570b\u969b\u77e5\u540dSCI\u91ab\u5b78\u671f\u520a
\u202212th International Conference on Oral Chelation 
  in the Treatment of Thalassaemia and Other Diseases (2002) 
  \u512a\u826f\u8ad6\u6587\u767c\u8868\u734e
\u2022\u53f0\u7063\u8840\u6db2\u75c5\u5b78\u67032006\u5e74\u9752\u5e74\u512a\u79c0\u8ad6\u6587\u734e
\u20222019\u5e74\u4e2d\u83ef\u6c11\u570b\u79c1\u7acb\u6559\u80b2\u4e8b\u696d\u6703 \u8cc7\u6df1\u66a8\u512a\u826f\u6559\u5e2b\u734e
\u2022\u79d1\u6280\u90e8(\u570b\u79d1\u6703) 2014\u30012015\u30012018\u30012019\u5e74\u8907\u5be9\u6703\u59d4\u54e1<\/p>\n\n\n\n

\u91ab\u5b78\u91cd\u8981\u6210\u5c31<\/strong>
(\u4e00)\u5152\u7ae5\u764c\u75c7: <\/strong>\u5c0d\u5404\u7a2e\u5152\u7ae5\u764c\u75c7\u6709\u5148\u9032\u7684\u6cbb\u7642\u548c\u6df1\u5165\u7684\u7814\u7a76
\u2022\u66fe\u520a\u65bc\u4e16\u754c\u9802\u5c16\u671f\u520aJournal of Clinical Oncology(\u767c\u8868\u65bc2002impact factor: 32.956)
\u2022\u767c\u73fe\u9ea9\u91af\u80fa\u9178(Glutamine)\u53ef\u986f\u8457\u964d\u4f4e\u767d\u8840\u75c5\u75c5\u7ae5\uff0c\u5728\u4f7f\u7528\u9ad8\u5291\u91cf\u5316\u7642\u85e5MTX\uff0c\u6240\u9020\u6210\u7684\u56b4\u91cd\u53e3\u8154\u6f70\u760d
\u2022\u591a\u7bc7\u8840\u764c\u76f8\u95dc\u7814\u7a76\uff0c\u7528\u7b2c\u4e8c\u4ee3\u6a19\u9776\u85e5\uff0c\u6210\u529f\u6cbb\u75ca\u8cbb\u57ce\u67d3\u8272\u9ad4\u6025\u6027\u6dcb\u5df4\u6027\u767d\u8840\u75c5\u9aa8\u9ad3\u79fb\u690d\u5f8c\u5fa9\u767c (\u767c\u8868\u65bcPediatr Blood Cancer 2013)
\u2022\u767c\u73fe\u4e16\u754c\u7b2c\u4e00\u4f4d\u9670\u8396\u6dcb\u5df4\u764c\u75c5\u7ae5\uff0c\u4e5f\u6210\u529f\u6cbb\u7642\uff0c\u6c92\u6709\u5f8c\u907a\u75c7 (\u767c\u8868\u65bcJ Pediatr Hematol Oncol 2006)
\u2022\u548c\u591a\u5bb6\u91ab\u5b78\u4e2d\u5fc3\u5408\u4f5c\uff0c\u767c\u73fe\u8a31\u591a\u8840\u764c\u7684\u76f8\u95dc\u57fa\u56e0\uff0c\u5c0d\u7cbe\u6e96\u91ab\u7642\u5f88\u6709\u52a9\u76ca\uff0c\u5c0d\u5404\u7a2e\u5152\u7ae5\u764c\u75c7\uff0c\u8840\u764c\u3001\u6dcb\u5df4\u764c\u3001\uff0c\u795e\u7d93\u6bcd\u7d30\u80de\u764c\u3001\u751f\u6b96\u7d30\u80de\u764c\u3001\u9aa8\u764c\u3001\u862d\u683c\u7f55\u6c0f\u7d44\u7e54\u7d30\u80de\u589e\u591a\u75c7\u3001\u5a01\u723e\u59c6\u6c0f\u7624\u2026.\u7b49\u90fd\u6709SCI\u570b\u969b\u671f\u520a\u767c\u8868
(\u4e8c). \u9aa8\u9ad3\u79fb\u690d<\/strong>: \u4e0d\u4f46\u6709\u9ad8\u7684\u6210\u529f\u7387\uff0c\u767c\u8868\u591a\u7bc7\u9020\u8840\u5e79\u7d30\u80de\u79fb\u690d
\u76f8\u95dc\u7814\u7a76
\u2022 \u5982\u4f55\u52a0\u901f\u81cd\u5e36\u8840\u79fb\u690d\u9020\u8840\u529f\u80fd\u7684\u6062\u5fa9 (\u767c\u8868\u65bcTransplantation 2013)
\u2022\u81ea\u9ad4\u81cd\u5e36\u8840\u79fb\u690d(\u767c\u8868\u65bcBone Marrow Transplant 2013)
\u2022\u79fb\u690d\u5f8c\u6392\u65a5\u7684\u6cbb\u7642 (\u767c\u8868\u65bcTransplantation 2011; Medicine 2017)
\u2022\u79fb\u690d\u5f8cBK\u75c5\u6bd2\u5f15\u8d77\u51fa\u8840\u6027\u8180\u80f1\u708e\u7684\u6cbb\u7642 
(\u767c\u8868\u65bcPediatr Infect Dis J 2014)\uff0c\u4e14\u88ab\u77e5\u540d\u611f\u67d3\u79d1\u6559\u79d1\u66f8\u201d\u71b1\u75c5\u201d\u5f15\u7528
\u2022\u9ef4\u83cc\u611f\u67d3\u7684\u8655\u7406 (\u767c\u8868\u65bcPediatr Transplant 2012; Ital J Pediatr 2016)
\u2022\u570b\u969b\u91ab\u7642\uff0c\u6210\u529f\u9aa8\u9ad3\u79fb\u690d\u6551\u6cbb\u8607\u4e39\u548c\u5370\u5c3c\u75c5\u7ae5
(\u4e09). \u8840\u6db2\u75be\u75c5<\/strong> (\u6d77\u6d0b\u6027\u8ca7\u8840\u3001\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u3001\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7\u3001
\u8f38\u8840\u91ab\u5b78)
\u2022\u6d77\u6d0b\u6027\u8ca7\u8840: \u767c\u8868\u6578\u5341\u7bc7\u6d77\u6d0b\u6027\u8ca7\u8840\u76f8\u95dc\u7814\u7a76\uff0c\u4e0d\u4f46\u81e8\u5e8a\u5e6b\u52a9\u53f0\u7063\u75c5\u60a3\uff0c\u4e5f\u5e6b\u52a9\u76f8\u540c\u75be\u75c5\u7684\u570b\u969b\u75c5\u4eba\u3002\u5408\u4f75\u4f7f\u7528\u6392\u9435\u5291\uff0c\u6210\u529f\u6551\u6cbb\u91cd\u5ea6\u6d77\u6d0b\u6027\u8ca7\u8840\u75c5\u60a3\u7684\u56b4\u91cd\u5fc3\u81df\u4f75\u767c\u75c7\uff0c\u4e0d\u4f46\u5e6b\u52a9\u9019\u6b7b\u4ea1\u7387\u6975\u9ad8\u7684\u554f\u984c\uff0c\u4e5f\u7372\u4e16\u754c\u5f88\u5927\u56de\u97ff\u3002 
(\u767c\u8868\u65bcAnn Hematol 2004; Ann Hematol 2020)
\u2022\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840: \u5f9e\u57fa\u790e\u5230\u6cbb\u7642\uff0c\u767c\u8868\u591a\u7bc7\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u7684\u6df1\u5165\u7814\u7a76\u3002\u4e26\u6df1\u5165\u7814\u7a76\u9593\u8cea\u5e79\u7d30\u80de\u5728\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u7684\u89d2\u8272\uff0c\u4e0d\u4f46\u662f\u9019\u65b9\u9762\u7684pioneer\uff0c\u4e5f\u7372\u4e16\u754c\u80af\u5b9a
(\u767c\u8868\u65bcAnn Hematol 2010; Pediatr Blood Cancer 2018)
\u2022\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7: \u767c\u73fe\u5152\u7ae5\u514d\u75ab\u8840\u5c0f\u677f\u4f4e\u4e0b\u7d2b\u6591\u75c7\u548c\u57fa\u56e0\u6709\u95dc\uff0c\u767c\u8868\u65bc\u4e16\u754c\u77e5\u540d\u7684\u671f\u520a (\u767c\u8868\u65bcBr J Haematol 2005)
\u2022\u8f38\u8840\u91ab\u5b78: \u767c\u73fe\u53f0\u7063\u7279\u6709\u7684\u7d05\u8840\u7403\u6297\u9ad4\uff0canti-Mia\u6703\u9020\u6210\u56b4\u91cd\u65b0\u751f\u5152\u9ec3\u75b8 (\u4e16\u754c\u7b2c\u4e8c\u4f8b\uff0c\u767c\u8868\u65bcTransfus Med 2002)
(\u56db). \u5e79\u7d30\u80de: <\/strong>\u70ba\u9593\u8cea\u5e79\u7d30\u80de\u7814\u7a76\u7684pioneer
\u2022\u4e16\u754c\u7b2c\u4e00\u4f4d\u5c07\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u61c9\u7528\u5230\u4eba\u9ad4\u4e0a\uff0c\u8b49\u660e\u5176\u5b89\u5168\u6709\u6548(\u767c\u8868\u65bcTransplantation 2011)
\u2022\u5f9e\u57fa\u790e\u5230\u52d5\u7269\uff0c\u61c9\u7528\u5230\u4eba\u9ad4\uff0c\u767c\u8868\u6578\u5341\u7bc7\u9593\u8cea\u5e79\u7d30\u80de\u76f8\u95dc\u7814\u7a76\uff0c
\u4e0d\u4f46\u5c0d\u9593\u8cea\u5e79\u7d30\u80de\u7814\u7a76\u5341\u5206\u6df1\u5165\uff0c\u4e5f\u70ba\u5c07\u4f86\u8f49\u8b6f\u91ab\u5b78\u7684\u61c9\u7528\uff0c\u7acb\u4e0b\u5f88\u597d\u7684\u57fa\u790e\u3002
\u2022\u767c\u73fe\u9ec3\u5176\u8403\u53d6\u7269(PG2)\u53ef\u52a0\u901f\u9593\u8cea\u5e79\u7d30\u80de\u7684\u751f\u9577\uff0c\u4e26\u52a0\u5f37\u514d\u75ab\u6291\u5236\u6548\u679c (\u767c\u8868\u65bcJ Ethnopharmacol 2017)
(\u4e94)\u5c0f\u5152\u79d1\u5b78: <\/strong>\u548c\u5c0f\u5152\u79d1\u91ab\u751f\u5408\u4f5c\uff0c\u767c\u8868\u8a31\u591a\u5152\u79d1\u76f8\u95dc\u7684\u7814\u7a76\uff0c\u5982\u611f\u67d3\uff0c\u514d\u75ab\u529b\u4f4e\u4e0b\uff0c\u6025\u91cd\u75c7..\u7b49<\/p>\n\n\n\n

\u91ab\u5b78\u8457\u4f5c<\/strong>
\u2022\u6d77\u6d0b\u6027\u8ca7\u8840\u662f\u4ec0\u9ebc\uff1f(\u51fa\u7248\u793e: \u5408\u8a18\u66f8\u5c40\u6709\u9650\u516c\u53f8)
\u2022\u95dc\u65bc\u5730\u4e2d\u6d77\u578b\u8ca7\u8840 (\u51fa\u7248\u793e: \u85dd\u8ed2\u5716\u66f8\u51fa\u7248\u793e)<\/p>\n\n\n\n

\u570b\u969b\u6703\u8b70\u9080\u8acb\u6f14\u8b1b(invited speaker)<\/strong>
\u2022Thalassemia and Aplastic Anemia: From Past to Present 
(Cross-Strait Hematology Conference, 2017)
\u2022Clinical application mesenchymal stem cells derived from umbilical 
cord in hematopoietic stem cell transplantation. 
(Perinatal Stem Cell Society Conference, USA, 2016)
\u2022Clinical application of mesenchymal stem cells derived from umbilical 
cord in hematopoietic stem cell transplantion
(AsiaCORD Conference, Japan, 2013)
\u2022Mesenchymal stem cells in hematopoietic stem cell transplantation
(Japan-K orea-Taiwan Symposium on Maternal-Fetal Medicine, 2012)
\u2022Comparisons of suppressive effects between human fetal-type
mesenchymal stem cells (MSCs) and bone marrow-derived MSCs
(Cross-Strait Hematology Conference, 2011)
\u2022Cotransplantation of hematopoietic stem cells and mesenchymal stem 
cells (Pan Pacific Symposium on Stem Cells and Cancer Research, 2008)<\/p>\n\n\n\n

\u7814\u7a76\u8a08\u5283<\/strong>
(1)\u79d1\u6280\u90e8\u8a08\u5283\uff1a<\/strong>
\u4e3b\u6301\u4eba:<\/strong>
\u2022\u5f9e\u81cd\u5e36\u8840\u53ca\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5171\u540c\u57f9\u990a\u5927\u91cf\u4eba\u985e\u8840\u7d05\u7d20 (2007-2008)
\u2022\u4eba\u985e\u4e0d\u540c\u4f86\u6e90\u9593\u8cea\u5e79\u7d30\u80de\u5728\u79fb\u690d\u6297\u5bbf\u4e3b\u75be\u75c5\u7684\u6bd4\u8f03\u548c\u6a5f\u8f49\u7814\u7a76 (2011-2012)
\u2022\u5152\u7ae5\u91cd\u5ea6\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u75c5\u60a3\u9aa8\u9ad3\u9593\u8cea\u5e79\u7d30\u80de\u514d\u75ab\u8abf\u6574\u529f\u80fd\u548c\u57fa\u56e0\u8868\u73fe\u7684\u7814\u7a76 (2013-1016)
\u2022\u80da\u80ce\u5230\u6210\u9ad4\u4e0d\u540c\u968e\u6bb5\u4e4b\u7d30\u80de\u4e0a\u6e05\u6db2\u514d\u75ab\u8abf\u6574\u529f\u80fd\u7684\u6bd4\u8f03\u8207\u6a5f\u8f49\u7814\u7a76 (2017-2018)
\u2022\u7814\u7a76\u4eba\u985e\u5404\u7a2e\u80ce\u5152\u7d44\u7e54\u5916\u6ccc\u9ad4\u7684\u514d\u75ab\u8abf\u6574\u529f\u80fd\u53ca\u5176\u6a5f\u8f49 (2018-2021)
\u5354\u540c\u4e3b\u6301\u4eba:<\/strong>
\u2022\u4e09\u968e\u6bb5\u652f\u6301\u6027\u8b77\u7406\u5c0d\u63a5\u53d7\u5e79\u7d30\u80de\u79fb\u690d\u75c5\u7ae5\u7167\u9867\u8005\u4e4b\u56f0\u64fe\u53ca\u751f\u6d3b\u54c1\u8cea\u6210\u6548\uff1a\u8de8\u6a5f\u69cb\u7e31\u8cab\u6027\u7814\u7a76(2016)
\u2022\u6bd4\u8f03\u4f86\u81ea\u4e0d\u540c\u80ce\u5152\u7d44\u7e54\u4e4b\u57f9\u990a\u6e05\u6db2\u8207\u9593\u8cea\u5e79\u7d30\u80de\u5c0d\u65bc\u6557\u8840\u75c7\u52d5\u7269\u7684\u514d\u75ab\u8abf\u7bc0\u6f5b\u529b\u8207\u6a5f\u8f49 (2016-2017)
\u2022\u5206\u6790\u5152\u7ae5\u56b4\u91cd\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u4e4b\u9aa8\u9ad3\u9593\u8cea\u5e79\u7d30\u80de\u53ca\u5176\u57f9\u990a\u6e05\u6db2 (2018-2019)
\u2022\u8a55\u4f30\u5152\u7ae5\u56b4\u91cd\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u4e4b\u9593\u8cea\u5e79\u7d30\u80de\u7684\u6539\u8b8a\u53ca\u9ec3\u8006\u5c0d\u5e79\u7d30\u80de\u7684\u5f71\u97ff (2019-2021)
(2)\u570b\u885b\u9662\u8a08\u5283\u4e3b\u6301\u4eba<\/strong>
\u2022104\u5e74\u5152\u79d1\u91cd\u96e3\u75c7\u91ab\u7642\u7167\u8b77\u5718\u968a\u734e\u52f5\u65b9\u6848\u8a08\u756b(\u5152\u7ae5\u764c\u75c7) 
\u2022105\u5e74\u5152\u79d1\u91cd\u96e3\u75c7\u91ab\u7642\u7167\u8b77\u5718\u968a\u734e\u52f5\u65b9\u6848\u8a08\u756b(\u5152\u7ae5\u764c\u75c7)
(3)\u885b\u751f\u798f\u5229\u90e8<\/strong>
\u2022\u6574\u5408\u53f0\u7063\u5152\u7ae5\u764c\u75c7\u81e8\u5e8a\u6cbb\u7642\u53ca\u5206\u5b50\u8a3a\u65b7: \u5152\u7ae5\u6025\u6027\u767d\u8840\u75c5\u4e4b\u91ab\u7642\u7d93\u6fdf\u5b78\u5206\u6790(2018-2022)
(4)\u7523\u5b78\u5408\u4f5c\u8a08\u5283\u4e3b\u6301\u4eba<\/strong>
\u2022\u8a0a\u806f\u751f\u7269\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u81cd\u5e36\u8840\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5171\u540c\u79fb\u690d(2007-2009) (\u7372\u7d93\u6fdf\u90e8\u5de5\u696d\u5c40\u5343\u842c\u7d93\u8cbb\u88dc\u52a9) 
\u2022\u5927\u5c55\u751f\u547d\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u7f3a\u8840\u53ca\u7f3a\u6c27\u6027\u9ad8\u5371\u96aa\u598a\u4e4b\u5a20\u81cd\u5e36\u8840\u4e3b\u52d5\u7559\u5b58\u76f8\u95dc\u91ab\u7642\u8f14\u52a9\u7814\u7a76 (2009\/01\/01-2009-12\/31)
\u2022\u8f1d\u745e\u5927\u85e5\u5ee0\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u4e00\u500b\u524d\u77bb\u6027\u3001\u958b\u653e\u6027\u6a19\u793a\u4e4b\u7814\u7a76\uff1a\u8a55\u4f30anidulafungin\u65bc\u6cbb\u7642\u4fb5\u5165\u6027\u5ff5\u73e0\u83cc\u611f\u67d3(\u5305\u62ec\u5ff5\u73e0\u83cc\u8840\u75c7)\u4e4b\u5152\u7ae5\u4e4b\u85e5\u7269\u52d5\u529b\u5b78\u3001\u5b89\u5168\u6027\u53ca\u7642\u6548 (2011-2013)
\u2022\u751f\u5bf6\u751f\u7269\u79d1\u6280\u80a1\u4efd\u6709\u9650\u516c\u53f8: \u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u6cbb\u7642\u6557\u8840\u75c7\u52d5\u7269\u7684\u5be6\u9a57\u548c\u6a5f\u8f49\u5206\u6790 (2012-2013)
\u2022\u53f0\u7063\u5c16\u7aef\u5148\u9032\u751f\u6280\u91ab\u85e5\u80a1\u4efd\u6709\u9650\u516c\u53f8: TAT-HOXB4\u86cb\u767d\u5c0d\u81cd\u5e36\u8840\u589e\u751f\u5f8c\u79fb\u690d\u6548\u679c (2013-2016)
(5)\u91ab\u5b78\u4e2d\u5fc3\u7814\u7a76\u8a08\u5283<\/strong>
\u4e3b\u6301\u4eba<\/strong>
\u2022\u798f\u5584\u7f8e\u9320(fosamax tablets)\u5728\u4e59\u578b\u91cd\u5ea6\u6d77\u6d0b\u6027\u8ca7\u8840\u75c5\u60a3\u9aa8\u8cea\u758f\u9b06\u7684\u6cbb\u7642(2005)
\u2022\u7531\u9031\u908a\u9020\u8840\u5e79\u7d30\u80de\u5728\u9ad4\u5916\u57f9\u990a\u6210\u4eba\u985e\u7d05\u8840\u7403(2007)
\u2022\u5f9e\u4eba\u985e\u80da\u80ce\u5e79\u7d30\u80de\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5171\u540c\u57f9\u990a\u4eba\u985e\u9020\u8840\u5e79\u7d30\u80de(2007)
\u2022\u9aa8\u9ad3\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u5728\u4e0d\u540c\u4ee3\u6578\u5c0dT\u6dcb\u5df4\u7d30\u80de\u6291\u5236\u4f5c\u7528\u7684\u6bd4\u8f03(2009)
\u2022\u4eba\u985e\u4e0d\u540c\u4f86\u6e90\u9593\u8cea\u5e79\u7d30\u80de\u5728\u79fb\u690d\u6297\u5bbf\u4e3b\u75be\u75c5\u548c\u514d\u75ab\u8abf\u6574\u529f\u80fd\u5728\u9ad4\u5167\u7684\u6bd4\u8f03\u53ca\u6a5f\u8f49\u7814\u7a76(2010)
\u2022\u96a8\u6a5f-\u96d9\u76f2\u8a66\u9a57-\u8a55\u4f30\u975c\u8108\u5de6\u65cb\u9ea9\u91af\u80fa\u9178\uff08L-Glutamine\uff09\u5c0d\u8a3a\u65b7\u70ba\u6025\u6027\u6dcb
\u2022\u5df4\u6027\u767d\u8840\u75c5\uff08ALL\uff09\u4e4b\u5152\u7ae5\u75c5\u60a3\u63a5\u53d7\u5316\u7642\u85e5\u7269\uff08MTX\uff09\u5f8c\u5f15\u8d77\u4e4b\u53e3\u8154\u9ecf\u819c\u708e\u3001\u71df\u990a\u53ca\u751f\u6d3b\u54c1\u8cea\u7684\u6539\u5584\u60c5\u5f62(2011)
\u2022\u4ee5\u4eba\u985e\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u4e0a\u6e05\u6db2\u6cbb\u7642\u6557\u8840\u75c7\u8001\u9f20(2013)
\u2022\u4ee5\u6642\u9593\u5e8f\u5217\u63a2\u8a0e\u548c\u6bd4\u8f03Toll-like\u53d7\u9ad4\u5728\u9aa8\u9ad3\u548c\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u6cbb\u7642\u6557\u8840\u75c7\u52d5\u7269\u6642\u7684\u6a5f\u8f49(2014)
\u2022\u9ec3\u8006\u5c0d\u81cd\u5e36\u9593\u8cea\u5e79\u7d30\u80de\u7684\u5f71\u97ff\u53ca\u5176\u6a5f\u8f49\u7684\u63a2\u8a0e(2015)
\u2022\u4ee5\u6642\u9593\u5e8f\u5217\u63a2\u8a0eToll-like\u53d7\u9ad4\u5728\u4eba\u985e\u7d68\u6bdb\u7d30\u80de\u4e0a\u6e05\u6db2\u6cbb\u7642\u6557\u8840\u75c7\u52d5\u7269\u6642\u7684\u6a5f\u8f49(2017)
\u2022\u63a2\u8a0e\u5152\u7ae5\u56b4\u91cd\u518d\u751f\u4e0d\u826f\u6027\u8ca7\u8840\u5e79\u7d30\u80de\u4e4b\u7f3a\u9677(2019)<\/p>\n\n\n\n

\u570b\u969bSCI\u96dc\u8a8c\u767c\u8868<\/strong>(2002-2020\uff0c\u6309\u5e74\u4ee3\u9806\u5e8f):\n\n<\/p>\n\n\n\n

  1. Wu KH<\/strong>,Chang JG, Lin M, Shih MC, Lin HC, Lee CC, Peng CT, Tsai CH.<\/a> Hydrops foetalis caused by anti-mur in firstpregnancy–a case report. Transfus Med. 2002;12:325-7.<\/li>
  2. Wu KH<\/strong>,Chu SL, Chang JG, Shih MC, Peng CT. Haemolytic disease of the newborn due tomaternal irregular antibodies in Chinese population in Taiwan. Transfus Med.2003;13:311-4.<\/li>
  3. Wu KH<\/strong>,Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with b-thalassemiamajor and the efficacy of recombinant GH treatment. Ann Hematol. 2003;82:637-40.<\/li>
  4. WuKH, <\/strong>Chang JS, Tsai CH, Peng CT. Combinedtherapy with deferiprone and desferrioxamine successfully regresses severeheart failure in patients with beta-thalassemia major. Ann Hematol. 2004;83:471-3.(Times Cited: <\/strong>57<\/strong><\/a> from Web of Science in 2020)<\/strong><\/li>
  5. Wu KH<\/strong>,Chang JS, Su BH, Peng CT.<\/a> Tricuspidregurgitation in patients with beta-thalassemia major. Ann Hematol. 2004;83:779-83. <\/li>
  6. ShihMC, Wu KH<\/strong>, Liu SC, Chang JG.<\/a> Hb Tak: a beta chain elongation at the end of the betachain, in a Taiwanese. Hemoglobin. 2005; 29:65-7.  <\/li>
  7. WuKH, <\/strong>Peng CT, Li TC, Wan L, Tsai CH, Lan SJ, ChangMC, Tsai FJ . Interleukin 4, interleukin 6 and interleukin 10 polymorphisms inchildren with acute and chronic immune thrombocytopenic purpura. Br J Haematol<\/strong>. 2005; 128:849-52. <\/li>
  8. PengCT, Wu KH<\/strong>, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH.<\/a> Amino acid concentrations in cerebrospinal fluid inchildren with acute lymphoblastic leukemia undergoing chemotherapy. Eur JCancer. 2005; 41:1158-63.<\/li>
  9. PengCT, Wu KH*<\/strong>, Wu SF, Liang DC, Yang CP, Jang RC, Wang LY, Hsiao CC.<\/a> Deferiprone or deferoxamine vs. combination therapy inpatients with beta-thalassemia major: a case study in Taiwan. Hemoglobin. 2006;30:125-30.(*corresponding author)<\/li>
  10. Kuo HT, Tsai MY, Peng CT, Wu KH<\/strong>.Pilot Study on \u201cQuality of Life\u201d as reflected by psychosocial adjustment ofchildren with thalassemia major undergoing iron-chelating treatment in westTaiwan. Hemoglobin.2006;30:291-9.<\/li>
  11. Wang CH, Wu KH<\/strong>, Tsai FJ, Peng CT.Comparison of oral and subcutaneous iron chelation therapy in prevention ofmajor endocrinopathies in b-thalassemiamajor patients. Hemoglobin.2006;30:257-62.<\/li>
  12. WuKH, <\/strong>Chang JG, Ho YJ, Wu SF, Peng CT.GlutathioneS-transferase M1 gene polymorphisms are associated with cardiac iron depositionin patients with b-thalassemiamajor.Hemoglobin.2006;30:251-6.<\/li>
  13. HuangYC, Chang JS, Wu KH<\/strong>, Peng CT. Regression of myocardial dysfunctionafter switching from deferoxamine to deferiprone in b-thalassemia major patients. Hemoglobin. 2006;30:229-38.<\/li>
  14. Wu SF, Peng CT, Wu KH<\/strong>, Tsai CH.Liverfibrosis and iron levels during long-term treatment of thalassemia majorpatients with deferiprone. Hemoglobin. 2006; 30:215-8.<\/li>
  15. Chen AC, Peng CT, Wu SF, Wu KH<\/strong>, ChiangIP, C-H Tsai CH.Effect of deferiprone on liver iron overload and fibrosis inhepatitis C virus infected thalassemia. Hemoglobin. 2006; 30:209-14.<\/li>
  16. Wei CC,Peng CT, Chiang IP, Wu KH*<\/strong>.Primary B cell non-Hodgkin\u2019s lymphoma of the penis in a child. J PediatrHematol Oncol. 2006; 28:479-80. (*correspondingauthor)<\/li>
  17. Wu KH<\/strong>,Peng CT, Li TC, Wan L, Tsai CH, Tsai FJ. Interleukin 1\u03b2 Exon 5 and interleukin1 receptor antagonist in children with acute and chronic immunethrombocytopenic purpura. J Pediatr Hematol Oncol. 2007; 29:305-8.<\/li>
  18. Peng CT<\/a>, Tsai CH<\/a>, WuKH<\/strong>. Effects of chelation therapy on cardiac function improvement inthalassemia patients: literature review and the Taiwanese experience. Hemoglobin.<\/a>2008;32:49-62.<\/li>
  19. WuSF, Chen AC, Peng CT, Wu KH*<\/strong>. Octreotide therapy in asparaginase-associatedpancreatitis in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer.<\/a>2008;51:824-5. (*corresponding author)<\/li>
  20. PengCT, Chang JS, Wu KH, <\/strong>Tsai CH, Lin SH. Mechanisms of and obstaclesto iron cardiomyopathy in thalassemia. FrontBiosci.<\/a> 2008; 13:5975-87.<\/li>
  21. Lin CH<\/a>, WuKH<\/strong>, Lin WC<\/a>, Tsai JD<\/a>, Peng CT<\/a>, Chen AC<\/a>. Granulocytic sarcoma of the colon in a child with acute myeloidleukemia presenting as hematochezia. J Pediatr Hematol Oncol.<\/a> 2008; 30:981-3.<\/li>
  22. ChangYH<\/a>, ShawCF<\/a>, Wu KH<\/strong><\/a>, HsiehKH<\/a>, SuYN<\/a>, LuPJ<\/a>. Treatment with deferiprone for iron overloadalleviates bone marrow failure in a Fanconi anemia patient. Hemoglobin.<\/a> 2009; 33: 346-51.<\/li>
  23. Peng CT<\/a>, Chang JS<\/a>, Wang LY<\/a>, Chiou SS<\/a>, Hsiao CC<\/a>, Wang SC<\/a>, Hung GY<\/a>, Wu KH<\/a>*<\/strong>.Update on thalassemia treatment in Taiwan, including bone marrowtransplantation, chelation therapy, and cardiomyopathy treatment effects. Hemoglobin.<\/a> 2009; 33:304-11. (*corresponding author)<\/li>
  24. Wu KH<\/strong>,Wang CH, Yang YL, Peng, CT, Lin WD, Tsai FJ, Lin DT, Bau DT. Significantassociation of XRCC4 single nucleotide polymorphisms with child leukemia inTaiwan. AnticancerRes.<\/a> 2010;30:529-34.<\/li>
  25. Liang DC, Yang CP, Lin DT, Hung IJ, Lin KH, Chen JS,Hsiao CC, Chang TT, Peng CT, Lin MT, Chang TK, Jaing TH, Liu HC, Wang LY, YehTC, Jou ST, Lu MY, Cheng CN, Sheen JM, Chiou SS, Wu KH<\/strong>, Hung GY, Chen RL, Chen SH, Cheng SN, Chang YH, ChenBW, Ho WL, Wang JL, Lin ST, Hsieh YL, Wang SC, Chang HH, Yang YL, Huang FL,Chang CY, Chang WH, Lin KS. Long-term results of Taiwan pediatric oncology group studies 1997and 2002 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:397-405.<\/li>
  26. LinCH, Lin WC, Chiang IP, Ho YJ, Peng CT, Wu KH<\/a>*<\/strong>.Langerhans cell histiocytosis with thyroid and lung involvement in a child: acase report. J Pediatr Hematol Oncol. 2010;32:309-11. (*corresponding author)<\/li>
  27. Lin CH, Lin WC, Wang CH, Ho YJ, Chiang IP, Peng CT, Wu KH<\/a>*<\/strong>. Child with ataxia telangiectasia developing acutemyeloid leukemia. J Clin Oncol.<\/strong> 2010; 28:213-4. (SCI: 32.956 in 2020)<\/strong> (*corresponding author)<\/li>
  28. LeeWI, Huang JL, Jaing TH, WuKH<\/strong>, Chien YH, Chang KW. Clinical aspects and genetic analysisof Taiwanese patients with Wiskott-Aldrich syndrome protein mutation: the firstidentification of x-linked thrombocytopenia in the Chinese with novelmutations. J ClinImmunol.<\/a> 2010; 30:593-601.<\/li>
  29. ChaoYH, Peng CT, Harn HJ, Chan CK, Wu KH<\/a>*<\/strong>. Poor potential of proliferation anddifferentiation in bone marrow mesenchymal stem cells derived from childrenwith severe aplastic anemia. Ann Hematol. 2010; 89:715-23. (*corresponding author)<\/li>
  30. WangCH, Wu KH<\/a>*<\/strong>,Yang YL, Peng CT, Wang RF, Tsai CW, Tsai RY, Lin DT, Tsai FJ, Bau DT.Association study of cyclooxygenase 2 single nucleotide polymorphisms andchildhood acute lymphoblastic leukemia in Taiwan. Anticancer Res. 2010;30:3649-3653. (*equal contribution author)<\/li>
  31. Yang YL, Lin SR, Chen JS, Hsiao CC, Lin KH, Sheen JM, Cheng CN, Wu KH<\/strong>, Lin SW, Yu SL, Chen HY,Lu MY, Chang HH, Yen CT, Lin JF, Su YH, Li YP, Lin CY, Jou ST, Lin DT.Multiplex reverse transcription-polymerase chain reaction as diagnosticmolecular screening of 4 common fusion chimeric genes in Taiwanese childrenwith acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010; 32:323-30.   <\/li>
  32. Chao YH, Tsai C, Peng CT, Wu HP, Chan CK, Weng TF, Wu KH<\/a>*<\/strong>. Cotransplantation of umbilical cord mesenchymal stemcells to enhance engraftment of hematopoietic stem cells in patients withsevere aplastic anemia. Bone Marrow Transplant. 2010; 46:1391-2 (*corresponding author)<\/li>
  33. Su BH, Wu KH\uff03<\/sup>, Lin HY, Lin MH, Peng CT, Tsai C. Umbilical cord-derivedmesenchymal stem cells for severe bronchpulmonary dysplasia. Pediatrics. 2011;26:1127-33. (\uff03<\/sup>equally author)<\/li>
  34. Wu KH, Chan CK, Tsai C, Chang YH, Sieber Martin, Chiu TH, Ho M,Peng CT, Wu HP, Huang JL. Effectivetreatment of severe steroid-resistant acute graft-versus-host disease withumbilical cord-derived mesenchymal stem cells. Transplantation. 2011; 91:1412-6.(Times Cited: <\/strong>78<\/strong><\/a> from Web of Science in 2020 )<\/strong><\/li>
  35. Yang WC, Chen JY, Wu KH<\/strong>,Wu HP. Acute onset of dizziness caused by a cavernous malformation lateralto the fourth ventricle: a case report. Pediatr Neonatol. 2011; 52:113-6.<\/li>
  36. ChaoYH, Wu HP, Chiang IP, Peng CT, Yang YL, Wu KH<\/a>*<\/strong>. Rhabdomyomatousdifferentiation in primary Wilms tumor and hepatic metastases afterchemotherapy and all-trans-retinoic acid in combination with interferon-\u03b1. PediatrBlood Cancer. 2011; 57:698-9. (*corresponding author)<\/li>
  37. Yang YL, Hung CC, Chen JS, Lin KH, Jou ST, Hsiao CC,Sheen JM, Cheng CN, Wu KH<\/strong>,Lin SR, Yu SL, Chen HY, Lu MY, Wang SC, Chang HH, Lin SW, Su YN, Lin DT. IKZF1deletions predict a poor prognosis in children with B-cell progenitor acutelymphoblastic leukemia: a multicenter analysis in Taiwan. Cancer Sci. 2011; 102:1874-81.<\/li>
  38. LeeWI*, Huang JL*, Jaing TH, Shyur SD, Yang KD, Chien YH, Chiang BL, Soong WJ,Chiou SS, Shieh CC, Lin SJ, Yeh KW, Chen LC, Ou LS, Yao TC, Lin TY, Chiu CH,Huang YC, Wu KH<\/strong>, Lin CY, YuHH, Yang YH, Yu HR, Yen HJ, Hsieh MY, Kuo ML, Hwu WL, Tsai YC, Kuo HC, Lin YL,Shih YF, Chang KW. Distribution,clinical features and treatment in Taiwanese patients with symptomatic primaryimmunodeficiency diseases (PIDs) in a nationwide population-based study during1985-2010. Immunobiology. 2011; 216:1286-94. (*corresponding author)<\/li>
  39. Li YC<\/a>, Chen CY<\/a>, Huang MY<\/a>, Wu KH<\/strong>, Yang WC<\/a>, Wu HP<\/a>. Significantchange between primary and repeated serum laboratory tests at different timepoints in pediatric appendicitis. Eur J Emerg Med.<\/a>2011; 19:395-9.<\/li>
  40. Yin-Yi Chang C, Wu KH,<\/strong> Lin TY,Chang WC, Lin WC, Hung YC, Yeh LS. Vulvar yolk sac tumor mixed withembryonal carcinoma in a peri-pubertal girl: A case report.<\/a> Taiwan J Obstet Gynecol. 2011; 50:503-5.<\/li>
  41. Wang CH,Wu KH<\/strong>, Yang YL, Peng CT, Tsai FJ, Lin DT, Chiu CF, Lin CC, Bau DT.Association between ataxia telangiectasia mutated gene polymorphisms and childhoodleukemia in Taiwan. Chin J Physiol. 2011; 54:413-8.<\/li>
  42. Chan CK, Wu KH\uff03<\/sup><\/strong>, Lee SH, Hwang SM, Lee MS,Liao SK, Cheng EH, See LC, Tsai CN, Kuo ML, Huang JL. The comparison of interleukin-6 associated immunosuppressiveeffects of human ESCs, fetal-type MSCs, and adult-Type MSCs. Transplantion. 2012;94:132-8 (\uff03<\/sup>equally author)<\/li>
  43. WengTF, Ho MW, Lin HC, Lu MY, Peng CT, Wu KH<\/a>*<\/strong>. Successfultreatment of disseminated mixed invasive fungal infection after hematopoieticstem cell transplantation for severe aplastic anemia. Pediatr Transplant. 2012;16:35-8. (*corresponding author)<\/li>
  44. Wu HP<\/a>, Yang WC<\/a>,Wu KH<\/strong><\/a>, Chen CY<\/a>, Fu YC<\/a>. Diagnosing appendicitis at different time pointsin children with right lower quadrant pain: comparison between pediatric appendicitisscore and the alvarado score. World JSurg.<\/a> 2012; 36:216-21.<\/li>
  45. Chen CY<\/a>, Yang WC<\/a>, Wu KH<\/strong><\/a>, Wu HP<\/a>. Clinicaljudgment of children with first-attack seizures admitted to the ED. Am J Emerg Med.<\/a> 2012Sep;30(7):1080-8.<\/li>
  46. YangYL, Hsiao CC, Chen HY, Lin KH, Jou ST, Chen JS, Chang TK, Sheen JM, Yu SL, LuMY, Cheng CN, Wu KH<\/strong>, Wang SC,Wang JD, Chang HH, Lin SR, Lin SW, Lin DT. Absence of biallelic TCR\u03b3 deletion predictsintroduction failure and poorer outcomes in childhood T-cell acute lymphoblasticleukemia. Pediatr Blood Cancer. 2012;58:846-51.<\/li>
  47. ChaoYH, Wu HP, Chan CK, Tsai C, Peng CT, WuKH*<\/strong>. Umbilical Cord-Derived Mesenchymal Stem Cells for HematopoieticStemCell Transplantation. J Biomed Biotechnol.<\/a> 2012;2012:759503.(*corresponding author)<\/li>
  48. ChaoYH, Wu KH<\/strong>, Lu JJ, Shih MC, Peng CT, Chang CW. RBCalloimmunization among Chinese patients with \u03b2-thalassemia major in Taiwan.Blood Transfus. 2013;11:71-74.<\/li>
  49. Wu KH<\/strong>,Tasi C, Wu HP, Sieber M, Chao YH, Peng CT. Human Application of Ex-VivoExpanded Umbilical Cord-Derived Mesenchymal Stem Cells: Enhance Hematopoiesisafter Cord Blood Transplantation. Cell Transplant. 2013;22:2041-51.<\/li>
  50. Liu CH, Wu KH<\/strong>,Lin TY, Wei CC, Lin CY, Chen XX, Lee WI.Wiskott-Aldrich syndrome with IgA nephropathy: a case report andliterature review. Int Urol Nephrol. 2013; 45:1495-500.<\/li>
  51. Wu KH<\/strong>,Wang SM, Wu HP, Weng T, Peng CT, Chao YH. Autologous cord blood transplantationin a child with stage 4 neuroblastoma. Bone Marrow Transplant. 2013;48:317-8.<\/li>
  52. Lin WC, Lin CH, Wu HP, Lin HC, Wu KH*<\/strong>. Simultaneous Pulmonary and Inferior Vena Cava ThromboembolismSecondary to Pelvic Osteosarcoma. J Pediatr Hematol Oncol.2013;35:e320-2 (*correspondingauthor)<\/li>
  53. Tamamyan G, Chao YH, Wang CH, Wu HP, Weng T, PengCT, Wu KH<\/strong>*. Dasatinib PlusChemotherapy to Achieve Full Donor Chimerism and Complete Molecular Remission ina Child with Relapsed Philadelphia Chromosome-positive Acute LymphoblasticLeukemia. Pediatr Blood Cancer. 2013;60:1727-1728 (*corresponding author)<\/li>
  54. Chen CY, Zhao LL, Lin YR, Wu KH<\/strong>, Wu HP*<\/sup>. Different urinalysis appearancesin children with simple and perforated appendicitis. Am J Emerg Med. 2013; 31:1560-1563.<\/li>
  55. Chao YH, Sheu JN, Chen SM, Wu KH<\/strong>*. Diagnostic Paracentesisin an Acute Lymphoblastic Leukemia Child without Characteristic Symptoms ofPancreatitis. Journalof Pediatric Hematology\/Oncology. 2013; 35:e47-e47. (*corresponding author)<\/li>
  56. WC Yang, YR Lin, LL Zhao, YK Wu, YJ Chang, CYChen, KH Wu<\/strong>, HP Wu*. Epidemiologyof Pediatric Critically-ill Patients Presenting to the Pediatric Emergency Department.Klinische Pediatrie. 2013;225:18-23.<\/li>
  57. Sheu JN, WuKH<\/strong>, Chen SM, Tsai JD, Chao YH, Lue KH*. Acute 99mTc DMSA Scan PredictsDilating Vesicoureteral Reflux in Young Children With a First Febrile UrinaryTract Infection: A Population-Based Cohort Study. Clinical Nuclear Medicine. 2013;38:163-168.<\/li>
  58. Wu KH<\/strong>, Sheu JN, Wu HP, Tsai C, Sieber M, Peng CT, Chao YH*. Cotransplantationof Umbilical Cord-Derived Mesenchymal Stem Cells Promote HematopoieticEngraftment in Cord Blood Transplantation: A Pilot Study. Transplantation. 2013;95:773-7.<\/li>
  59. Wang CH, Lai YL, Chang WS, Wu KH<\/strong>, Lane HY, Chiu CF, TsaiFJ, Lin CC, Bau DT. Significant Association of Caveolin-1 Single NucleotidePolymorphisms with Childhood Leukemia in Taiwan. Cancer Genomics Proteomics. 2013;10:75-79.<\/li>
  60. Wu KH<\/strong>, Wu HP, Chan CK, Hwang SM, Peng CT, Chao YH.The Role ofMesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation: from Benchto Bedsides. Cell Transplant. 2013;22:723-729.  <\/li>
  61. Chen CY, Lin YR, Zhao LL, Wu YK, Chang YJ,Yang WC, Wu KH<\/strong>, Wu HP. Epidemiologyand outcome analysis of children with traumatic out-of-hospital cardiac arrestcompared to nontraumatic cardiac arrest. Pediatr Surg Int. 2013; 29:471-477.<\/li>
  62. Sun HL,Wu KH<\/strong>, Chen SM, Chao YH, Ku MS, Hung TW, Liao PF, Lue KH, Sheu JN. Roleof Procalcitonin in Predicting Dilating Vesicoureteral Reflux in Young ChildrenHospitalized. Pediatr Infect Dis J. 2013; 32:e348-e354.<\/li>
  63. Chen CY, Lin YR, Zhao LL, Yang WC, Chang YJ, Wu KH<\/strong>, Wu HP. Clinical spectrumof rhabdomyolysis presented to pediatric emergency department. BMC Pediatrics. 2013;13:1-6.<\/li>
  64. Lin WC, Lin CH, Chao YH, Lin HC, Chen PY, WuHP, Wu KH<\/strong>*<\/sup>. SimultaneousPulmonary and Inferior Vena Cava Thromboembolism Secondary to PelvicOsteosarcoma. J Pediatr Hematol Oncol. 2013; 35:e320-e322. (*corresponding author)<\/li>
  65. Chao YH, WuKH<\/strong>, Lin CY, Tsai MH, Peng CT, Wu HP, Lin CD. Audiologic and VestibularAssessment in Patients With \u03b2-Thalassemia Major Receiving Long-Term Transfusion Therapy. PediatrBlood Cancer. 2013;60:1963-6.  <\/li>
  66. Wu KH<\/strong>, Chan CK, Chao YH, Peng CT, Huang JL. Clinical Considerationfor Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation. Transplantation.2013; 96:e86-e87.  <\/li>
  67. Lin CY, Li MJ, Chang JG, Liu SC, Weng T, Wu KH<\/strong>, Yang SF, Huang FK, Lo WY,Peng CT. High-resolution melting analyses for genetic variants in ARID5B andIKZF1 with childhood acute lymphoblastic leukemia susceptibility loci inTaiwan. Blood Cells Mol Dis. 2014; 2014:140-145.<\/li>
  68. Chao YH, Wu HP, Wu KH<\/strong>#<\/sup>, Tsai YG, Peng CT, Lin KC, Chao WR, LeeMS, Fu YC. An increase in CD3+CD4+CD25+ regulatory T cells after administrationof umbilical cord-derived mesenchymal stem cells during sepsis. PLoS One. 2014;9:e110338 (#equal contribution)<\/li>
  69. Wu KH,<\/strong> Weng T, Wu HP, Peng CT, Sheu JN, Chao YH. Effectivetreatment of severe BK virus-associated hemorrhagic cystitis with leflunomidein children after hematopoietic stem cell transplantation: a pilot study.Pediatr Infect Dis J. 2014; 33:1193-5.<\/li>
  70. Chao YH, WuKH<\/strong>#<\/sup>, Wu HP, Liu SC, Peng CT, Lee MS. Clinical features andmolecular analysis of Hb H disease in Taiwan. Biomed Res Int. 2014:271070. (#equalcontribution)<\/li>
  71. Cho FN, Chang TH, Shu CW, Ko MC, Liao SK, Wu KH<\/strong>, Yu MS, Lin SJ, Hong YC,Chen CH, Hung CH, Chang YH. Enhanced cytotoxicity of natural killer cellsfollowing the acquisition of chimeric antigen receptors through trogocytosis.PLoS One. 2014;9:e109352.<\/li>
  72. Chao YH, Wu KH#<\/sup>, Chiou SH, ChiangSF, Huang CY, Yang HC, Chan CK, Peng CT, Wu HP, Chow KC, Lee MS. DownregulatedCXCL12 expression in mesenchymal stem cells associated with severe aplasticanemia in children. Ann Hematol. 2015;94:13-22. (#<\/sup>equal contribution)<\/li>
  73. Wu KH<\/strong>, Wu HP, Weng T, Peng CT, Chao YH. Dasatinib for a childwith Philadelphia chromosome-positive acute lymphoblastic leukemia andpersistently elevated minimal residual disease during imatinib therapy. CurrOncol. 2015; 22:303-306.<\/li>
  74. LiYC, Chen CY, Wu KH<\/strong>, Kuo HT,Wu HP. Recurrent Streptococcus Pneumoniae 23 Fmeningitis due to cerebrospinal fluid leakage fromthe ear cannel: a case report. BMC Pediatr. 2015;15:195.<\/li>
  75. Lin CH, Lin WC, Lai IH, Wu SF, Wu KH<\/strong>, Chen AC. Pediatric gastric cancer presenting withmassive ascites. World J Gastroenterol. 2015;21:3409-13.<\/li>
  76. Wu KH<\/strong>, Chao WR, Lo WY, Tseng PC, Lee CJ, Peng CT, Lee MS, WuHP, Chao YH. Time-Series Expression of Toll-Like Receptor 4 Signaling in SepticMice Treated With Mesenchymal Stem Cells. Shock. 2016;45:634-40.<\/li>
  77. YenHJ, Chang WH, Liu HC, Yeh TC, Hung GY, WuKH<\/strong>, Peng CT, Chang YH, Chang TK, Hsiao CC, Sheen JM, Chao YH, Chang TT,Chiou SS, Lin PC, Wang SC, Lin MT, Ho WL, Chen YC, Liang DC. Outcomes FollowingDiscontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions inChildren With Acute Lymphoblastic Leukemia. Pediatr Blood Cancer.2016;63:665-70.<\/li>
  78. Weng TF, Wu KH<\/strong>#<\/sup>, Wu HP, Peng CT, Chao YH. Changes of serum aspergillusgalactomannan during hematopoietic stem cell transplantation in children withprior invasive aspergillosis. Ital J Pediatr. 2016;42:30. (#equal contribution)<\/li>
  79. Chen CY, Kuo HT, Chang YJ, Wu KH<\/strong>, Yang WC, Wu HP. Clinical assessment of children withrenal abscesses presenting to the pediatric emergency department. BMC Pediatr.2016;16:189.<\/li>
  80. Wu KH<\/strong>, Wu HP, Lin HJ, Wang CH, Chen HY, Weng T, Peng CT, ChaoYH. Concurrent hypopituitarism and leukemic retinopathy in a child withB-precursor acute lymphoblastic leukemia and isolated central nervous systemrelapse. Curr Oncol. 2016;23:e431-4.<\/li>
  81. Chuncharunee S, Wong R, Rojnuckarin P, Chang CS, ChangKM, Lu MY, Hwang WL, Koh LP, Chen TY, Leung AY, Norasetthada L, Wang SC, ChangMC, Wu KH<\/strong>, Issaragrisil S. Efficacyof rabbit antithymocyte globulin as first-line treatment of severe aplasticanemia: an Asian multicenter retrospective study. Int J Hematol.2016;104:454-61.<\/li>
  82. Lin HC, Chao YH, WuKH<\/strong>, Yen TY, Hsu YL, Hsieh TH, Wei HM, Wu JL, Muo CH, Hwang KP, Peng CT,Lin CC, Li TC. Increased risk of herpes zoster in children with cancer: Anationwide population-based cohort study. Medicine (Baltimore). 2016; 95:e4037.<\/li>
  83. Chan CK, Lin TC, Huang YA, Chen YS, Wu CL, Lo HY, Kuo ML,Wu KH*<\/sup><\/strong>, Huang JL. Themodulation of Th2 immune pathway in the immunosuppressive effect of humanumbilical cord mesenchymal stem cells in a murine asthmatic model. Inflamm Res.2016;65:795-801.(*corresponding author)<\/li>
  84. Yang CA, Lin JA, Chang CW, Wu KH<\/strong>, Yeh SP, Ho CM, Chang JG. Selection of GP. Murantigen-negative RBC for blood recipients with anti-‘Mia ‘ records decreasestransfusion reaction rates in Taiwan. Transfus Med. 2016;26:349-354.<\/li>
  85. Huang MY, Chen CY, Chien JH, Wu KH, Chang Y, Wu KH<\/strong>, Wu HP. SerumProcalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patientswith Severe Sepsis and Septic Shock. Biomed Res Int. 2016;2016:1758501.<\/li>
  86. Lin CH, Chao YH, WuKH<\/strong>, Lin WC. Primary mucoepidermoid carcinoma at the carina of tracheapresenting with wheezing in an asthmatic child mimicking an attack of asthma: Acase report. Medicine (Baltimore). 2016;95:e5292.<\/li>
  87. Yang WC, Kuo HT, Lin CH, Wu KH<\/strong>, Chang YJ, Chen CY, Wu HP. Tympanic temperature versustemporal temperature in patients with pyrexia and chills. Medicine (Baltimore).2016;95:e5267.<\/li>
  88. Wu HP, Lin CL, Chang YC, Wu KH<\/strong>, Lei RL, Peng CT, Weng T, Tai YM, Chao YH. Survivaland complication rates in patients with thalassemia major in Taiwan. PediatrBlood Cancer. 2017;64:135-8.<\/li>
  89. Li MJ, Liu HC, Yen HJ, Jaing TH, Lin DT, Yang CP, Lin KH,Hung IJ, Jou ST, Lu MY, Hsiao CC, Peng CT, Chang TT, Wang SC, Lin MT, Chen JS,Chang TK, Hung GY, Wu KH<\/strong>,Yang YL, Chang HH, Chen SH, Yeh TC, Cheng CN, Lin PC, Chiou SS, Sheen JM, ChengSN, Chen SH, Chang YH, Ho WL, Chao YH, Chen RL, Chen BW, Wang JL, Hsieh YL,Liao YM, Yang SH, Chang WH, Chao YY, Liang DC. Treatment for childhood acutelymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002study emphasizing optimal reinduction therapy and central nervous systempreventive therapy without cranial radiation. Pediatr Blood Cancer.2017;64:234-241.<\/li>
  90. Sun KT, Huang YN, Palanisamy K, Chang SS, Wang IK, Wu KH<\/strong>, Chen P, Peng CT, Li CY. Reciprocalregulation of \u03b3-globin expression by exo-miRNAs: Relevance to \u03b3-globinsilencing in \u03b2-thalassemia major. Sci Rep. 2017;7:202.<\/li>
  91. Wu HP, Lin MJ, Yang WC, Wu KH<\/strong>, Chen CY. Predictors of Extracorporeal MembraneOxygenation Support for Children with Acute Myocarditis. Biomed Res Int. 2017:2510695.<\/li>
  92. Chang YH, Yu MS, WuKH<\/strong>, Hsu MC, Chiou YH, Wu HP, Peng CT, Chao YH. Effectiveness of ParenteralGlutamine on Methotrexate-induced Oral Mucositis in Children with AcuteLymphoblastic Leukemia. Nutr Cancer. 2017l;69:746-51.<\/li>
  93. Yen HJ, Chen SH, Chang TY, Yang CP, Lin DT, Hung IJ, LinKH, Chen JS, Hsiao CC, Chang TT, Chang TK, Peng CT, Lin MT, Jaing TH, Liu HC,Jou ST, Lu MY, Cheng CN, Sheen JM, Chiou SS, Hung GY, Wu KH<\/strong>, Yeh TC, Wang SC, Chen RL, Chang HH, Yang YL, Chen SH,Cheng SN, Chang YH, Chen BW, Hsieh YL, Huang FL, Ho WL, Wang JL, Chang CY, ChaoYH, Lin PC, Chen YC, Liao YM, Lin TH, Shih LY, Liang DC. Pediatric acutelymphoblastic leukemia with t(1;19)\/TCF3-PBX1 in Taiwan. Pediatr Blood Cancer.2017;64:e26557.<\/li>
  94. Chao YH, Wu KH<\/strong>,Lin CW, Yang SF, Chao WR, Peng CT, Wu HP. PG2, a botanically derived drugextracted from Astragalus membranaceus, promotes proliferation andimmunosuppression of umbilical cord-derived mesenchymal stem cells. JEthnopharmacol. 2017;207:184-91.<\/li>
  95. Chao YH, Chang YC, Wu HP, Peng CT, Weng TF, Wu KH*<\/sup><\/strong>. Everolimusfor pediatric patients with acute graft-versus-host disease after hematopoieticstem cell transplantation: A pilot study. Medicine (Baltimore). 2017;96:e8464. (*corresponding author)
    <\/li>
  96. Chao YH, Lin CW, Pan HH, Yang SF, Weng TF, Peng CT, Wu KH*<\/sup><\/strong>. Increasedapoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymalstem cells in severe aplastic anemia. Pediatr Blood Cancer. 2018; e27247. (*corresponding author)
    <\/li>
  97. Yeh TC, Liang DC, Hou JY, Jaing TH, Lin DT, Yang CP, PengCT, Hung IJ, Lin KH, Hsiao CC, Jou ST, Chiou SS, Chen JS, Wang SC, Chang TK, Wu KH<\/strong>, Sheen JM, Yen HJ, ChenSH, Lu MY, Li MJ, Chang TT, Huang TH, Chang YH, Chen SH, Yang YL, Chang HH,Chen BW, Lin PC, Cheng CN, Chao YH, Yang SH, Chao YY, Liu HC. Treatment ofchildhood acute lymphoblastic leukemia with delayed first intrathecal therapyand omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002study. Cancer. 2018;124:4538-4547.
    <\/li>
  98. Lin CH, Chen X, Wu CC, Wu KH<\/strong>, Song TS, Weng TF, Hsieh YW, Peng CT. Therapeuticmechanism of combined oral chelation therapy to maximize efficacy of ironremoval in transfusion-dependent thalassemia major – a pilot study. Expert RevHematol. 2019;12:265-272.
    <\/li>
  99. Wang HH, Liao LN, Chang CW, Chang YC, Wu KH<\/strong>, Ko JL. The alteration offerritin and transferrin saturation under body mass index and blood pressure infirst-time and regular male blood donors in Taiwan. Medicine (Baltimore).2019;98:e15854.
    <\/li>
  100. Chen SH, Chen JS, Jou ST, Wu KH<\/strong>, Hung IJ, Sheen JM, Lu MY, Chen BW, Jaing TH, Wang SC,Lin MT, Chang TK, Liu HC, Yang CP. Outcome and prognosis of anaplastic largecell lymphoma in children: a report from the Taiwan Pediatric Oncology Group.Leuk Lymphoma. 2019;60:1942-1949.
    <\/li>
  101. Chen CH, Wu KH<\/strong>,Chao YH, Weng DF, Chang JS, Lin CH. Clinical manifestation of pediatricmediastinal tumors, a single center experience. Medicine (Baltimore). 2019;98:e16732.
    <\/li>
  102. Chao YH, Wu KH<\/strong>.Transfusion-related immunomodulation in pediatric patients. Pediatr Neonatol.2019;60:483-484.
    <\/li>
  103. Yu CH, Chang WT, Jou ST, Lin TK, Chang YH, Lin CY, LinKH, Lu MY, Chen SH, Wu KH<\/strong>,Wang SC, Chang HH, Su YN, Hung CC, Lin DT, Chen HY, Yang YL. TP53 alterationsin relapsed childhood acute lymphoblastic leukemia. Cancer Sci. 2020;111:229-238.
    <\/li>
  104. Wu KH<\/strong>, Cheng CC, Li JP, Weng TF, Yang SF, Pan HH, Chao YH.Toll-like receptor signalling associated with immunomodulation of umbilicalcord\u2013derived mesenchymal stem cells in mice with systemic lupus erythematosus.Lupus. 2020;29:165-175.
    <\/li>
  105. Hsia NY, Lin CJ, Lin HJ, Wu KH<\/strong>. Foveal photoreceptors loss and then recovery aftertreatment in a chronic myelogenous leukemia patient. Pediatr Hematol Oncol.2020;37:545-548.
    <\/li>
  106. Yu CH, Lin TK, Jou ST, Lin CY, Lin KH, Lu MY, Chen SH,Cheng CN, Wu KH<\/strong>, Wang SC,Chang HH, Li MJ, Ni YL, Su YN, Lin DT, Chen HY, Harrison CJ, Hung CC, Lin SW,Yang YL. MLPA and DNA index improve the molecular diagnosis of childhood B-cellacute lymphoblastic leukemia. Sci Rep. 2020;10:11501.
    <\/li>
  107. Yu SL, Zhang H, Ho BC, Yu CH, Chang CC, Hsu YC, Ni YL,Lin KH, Jou ST, Lu MY, Chen SH, Wu KH<\/strong>,Wang SC, Chang HH, Pui CH, Yang JJ, Zhang J, Lin DT, Lin SW, Ma X, Yang YL.FPGS relapse-specific mutations in relapsed childhood acute lymphoblasticleukemia. Sci Rep. 2020;10:12074.
    <\/li>
  108. Chuang TY, Li JP, Weng TF, Wu KH<\/strong>, Chao YH. Combined chelation with high-dosedeferiprone and deferoxamine to improve survival and restore cardiac functioneffectively in patients with transfusion-dependent thalassemia presentingsevere cardiac complications. Ann Hematol. 2020 Jul 31. in press<\/li><\/ol>\n\n\n\n

    \u570b\u969b\u77e5\u540dSCI\u91ab\u5b78\u671f\u520a\u8ad6\u6587\u5be9\u7a3f\u5b78\u8005(reviewer)<\/strong>
    \u2022Pediatrics
    \u2022Cell transplantation
    \u2022Transplantation
    \u2022Annals of Hematology
    \u2022Stem Cells International, Acta Haematologica
    \u2022Cell Biochemistry and Biophysics
    \u2022Journal of the Chinese Medical Association
    \u2022Mycopathologia
    \u2022Journal of the Formosan Medical Association
    \u2022Pediatrics and Neonatology.\n\n<\/p>\n","protected":false},"excerpt":{"rendered":"

    \u91ab\u5e2b\u59d3\u540d\uff1a\u5deb\u5eb7\u7199\u3000(Wu, Kang-Hsi)\u3000 \u73fe\u8077\/\u6559\u8077\u2022\u4e2d\u5c71\u91ab\u5b78\u5927\u5b78\u9644\u8a2d\u91ab\u9662 \u5152\u7ae5\u8840\u6db2\u816b\u7624\u79d1 \u4e3b\u4efb\u2022\u4e2d\u5c71 […]<\/p>\n","protected":false},"author":32,"featured_media":0,"parent":2648,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5601","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/pages\/5601"}],"collection":[{"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5601"}],"version-history":[{"count":51,"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/pages\/5601\/revisions"}],"predecessor-version":[{"id":22958,"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/pages\/5601\/revisions\/22958"}],"up":[{"embeddable":true,"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=\/wp\/v2\/pages\/2648"}],"wp:attachment":[{"href":"https:\/\/web.csh.org.tw\/web\/doctor\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}